ðɪ ˌændɹoʊdʒˈɛnɪk pɹˈɑːpɚɾiz ʌv dʒˈɛstɹɪnˌɑːn ɑːɹ mˈoːɹ ɛksplˈɔɪɾᵻd ɪn ɪts dᵻɹˈɪvətˌɪv tˈɛtɹɐhˌaɪdɹoʊdʒstɹˌɪnɑːn tˌiːˌeɪtʃdʒˈiː; sˈɛvəntˌiːn ˈælfəˈɛθəl ˈeɪtiːnmˈɛθəldˈɛltə nˈaɪn,ɪlˈɛvən dˈæʃ nˈaɪntiːnnˌɔːɹɾɪstˈɑːstɚɹˌoʊn, ɐ dɪzˈaɪnɚ stˈɛɹɔɪd wˌɪtʃ ɪz fˈɑːɹmˌoːɹ pˈoʊtənt æz bˈoʊθ ɐn ˌeɪˌeɪˈɛs ænd pɹoʊdʒˈɛstədʒən ɪn kəmpˈæɹɪsən.
The androgenic properties of gestrinone are more exploited in its derivative tetrahydrogestrinone (THG; 17α-ethyl-18-methyl-δ9,11-19-nortestosterone), a designer steroid which is far more potent as both an AAS and progestogen in comparison.